Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

CompletedOBSERVATIONAL
Enrollment

827

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

September 11, 2024

Study Completion Date

September 11, 2024

Conditions
EpilepsySeizuresDrug Resistant Epilepsy
Interventions
DEVICE

Vagus Nerve Stimulation (VNS) Therapy

The VNS Therapy System is a commercially available device that will be used by licensed medical practitioners trained in the use of VNS Therapy, per the practitioners' medical judgement.

Trial Locations (62)

3004

The Alfred Hospital, Melbourne

3050

The Royal Melbourne Hospital, Melbourne

4020

Kepler Universitätsklinikum, Linz

4101

Queensland Children's hospital, Brisbane

9000

Universitair Ziekenhuis Gent, Ghent

13210

State University of New York, Syracuse

14226

Dent Neurosciences Research Center, Amherst

15212

Allegheny Neurology Associates, Pittsburgh

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

20007

Georgetown University Medical Center, Washington D.C.

22601

Valley Health System, Winchester

27157

Wake Forest University, Winston-Salem

27710

Duke University Hospital, Durham

32806

Research Institute of Orlando, Orlando

33609

Pediatric Epilepsy & Neurology Specialists, Tampa

38103

Le Bonheur Children's Hospital, Memphis

40139

Ospedale Bellaria, Bologna

53211

Ascension Columbia St. Mary's Hospital, Milwaukee

67214

Via Christi Health, Wichita

70112

Tulane University, New Orleans

78229

University of Texas Health Science Center at San Antonio, San Antonio

78731

Child Neurology Consultants of Austin, Austin

81501

St. Mary's Hospital, Grand Junction

96817

Hawaii Pacific Neuroscience, Honolulu

400016

P.D. Hinduja National Hospital, Mumbai

411004

Deenanath Mangeshkar Hospital and Research Centre, Pune

4920235

Schneider Children's Medical Center of Israel, Petah Tikva

Unknown

Royal Children's hospital, Melbourne

UCL Saint-Luc, Brussels

Fundação Felice Rosso, Hospital Felício Rocho, Belo Horizonte

Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro

Sanbo Brain Hospital Capital Medical University, Beijing

Xuanwu Hospital Capital Medical University, Beijing

Guangzhou Women and Children's Medical Center, Guangzhou

St.-John Medical College and Hospital, Bangalore

Sheba Medical Center, Ramat Gan

Sourasky Medical Center, Tel Aviv

Bambino Gesu Pediatric Hospital, Rome

National Center Hospital of Neurology and Psychiatry, Kodaira

National Hospital Organization Nagasaki Medical Center, Nagasaki

The University of Tokyo Hospital, Tokyo

Kempenhaeghe, Heeze

Stichting Epilepsie Instellingen Nederland (SEIN), Zwolle

Centro Hospitalar de São João, Porto

King Faisal Specialist Hospital & Research Center, Jeddah

King Faisal Specialist Hospital & Research Center, Riyadh

King's College Hospital, London

Royal Victoria Infirmary Hospital, Newcastle upon Tyne

Norfolk and Norwich Hospitals NHS Foundation Trust, Norwich

John Radcliffe Hospital, Oxford

Royal Hallamshire Hospital, Sheffield

W1 6909

Perth Children's Hospital, Perth

N6A 5A5

London Health Sciences Centre Research Inc., London

N6C 2R5

London Health Sciences Centre Research Inc. (London Victoria), London

H2X 0C1

Centre Hospitalier de l'Université de Montréal, Montreal

H3A 2B4

Montreal Neurological Institute and Hospital, Montreal

H3H 2R9

The Research Institute of the McGill University Health Centre, Montreal

3015 GD

Sophia Kinderziekenhuis, Rotterdam

40-752

University Clinical Center, Katowice

04-730

Children's Memorial Health Institute, Warsaw

BS10 5NB

Southmead Hospital, Bristol

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LivaNova

INDUSTRY

NCT03529045 - Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. | Biotech Hunter | Biotech Hunter